Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 – 10:36

Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 – 11:09

A Phase 1 clinical trial has demonstrated the safety and efficacy of a novel immunotherapy drug in the […]

CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say badams Tue, […]

AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this […]

Biogen’s Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner […]

FDA commissioner nominee Califf makes ethics pledge to Sen. Warren in bid for her support: report fkansteiner Mon, […]

Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late? esagonowsky Mon, 01/31/2022 – 15:28

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a predictive computer programme that […]

Pioneering Artificial Intelligence (AI) technology, developed by experts at University of the West of Scotland (UWS), is capable […]